pharma letter lab workersThe Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the Pharmaceuticals, Biotechnology and Generics sectors of the overall health care industry, backed by a team of respected writers with many years of experience in the field.

Register for free for our daily email newsletter and  to get access to premium content for 7 days free!

Latest Pharma Letter Articles

Pharmaceutical

features_upload_img_2

New Global Vaccine Action Plan does not go far enough, says MSF

18 May 2012

A new, 10-year, multi-billion dollar action plan for global vaccination may fail to deliver

Complete responses in Phase I trial of crizotinib in rare childhood cancer

18 May 2012

A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging

Biotechnology

features_upload_img_3

Optimism and concerns of Netherlands' Biotech industry

17 May 2012

Major trends and developments in the Dutch biotechnology sector, mainly based on the expectations

Blueprint to boost R&D for diseases of the developing world

17 May 2012

A new study, commissioned by the International Federation of Pharmaceutical Manufacturers and

Generics

features_upload_img_4

US FDA approves generic versions of blood thinner Plavix

18 May 2012

Coinciding with the loss of patent protection on Sanofi (Euronext: SAN) and Bristol-Myers Squibb's

Bristol-Myers anticipates significant decline in US clopidogrel sales as patent lapses

17 May 2012

GenericsWeb, a patent analysis and search company, recently published an article based on its